Literature DB >> 32144718

Germanium Reduces Inflammatory Damage in Mammary Glands During Lipopolysaccharide-Induced Mastitis in Mice.

Yong-Sheng Wang1, Guo-Qing Teng2, Han Zhou3, Chun-Liu Dong3.   

Abstract

Ge is a trace element needed for good nutrition and health protection in animals and humans. Ge can be consumed by drinking or eating or administered by injection and transferred with the blood to exert pharmacological activities. The blood is important in the formation of milk. Mastitis is a serious health hazard in animals and humans. The present study explored the effect of Ge on mastitis and the potential underlying mechanism. A mastitis mouse model was established with LPS. mMECs were prepared for study in vitro. Histopathological changes showed that Ge had a protective effect on mammary gland tissues. Ge inhibited MPO activity to reduce inflammatory cell infiltration during mastitis. ELISA and qPCR results for tissues and cells showed that the expression of TNF-α, IL-1β, and IL-6 was decreased and that of IL-10 was increased by Ge in a dose-dependent manner in mastitis. An analysis of protein phosphorylation was performed with sandwich ELISAs for both tissues and mMECs. The results showed that Ge significantly inhibited the phosphorylation of IκB, NF-κB p65, p38, ERK, and JNK, which was dramatically increased by LPS. These results demonstrate that Ge has an inhibitory effect on inflammation that protects mammary gland tissues by inhibiting NF-κB and MAPK pathway activation and reducing TNF-α, IL-1β, and IL-6 expression. Ge may be an effective clinical treatment for mastitis and other inflammatory diseases.

Entities:  

Keywords:  Germanium; Inflammation; MAPKs signal path; Mastitis; NF-κB signal path

Mesh:

Substances:

Year:  2020        PMID: 32144718     DOI: 10.1007/s12011-020-02106-x

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  2 in total

1.  Exploring the Action Mechanism of the Active Ingredient of Quercetin in Ligustrum lucidum on the Mouse Mastitis Model Based on Network Pharmacology and Molecular Biology Validation.

Authors:  Lu Cao; Tao Wang; XiaoYu Mi; Peng Ji; XingXu Zhao; Yong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-10       Impact factor: 2.650

2.  Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation.

Authors:  Ronald Neil Kostoff; Michael Brandon Briggs; Darla Roye Shores
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.